ZimVie's CEO Vafa Jamali joins Let's Talk Medtech in an exclusive interview about how the company is poised to transform the dental and spine markets. The company has now been completely spun out from Zimmer Biomet and is trading on the Nasdaq. With strong leadership and a strong product portfolio, ZimVie is poised to be one of the breakout companies of the year in medtech.
